Podchaser Logo
Home
104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

Released Wednesday, 22nd May 2024
Good episode? Give it some love!
104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

Wednesday, 22nd May 2024
Good episode? Give it some love!
Rate Episode

 In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.

Ketamine

DMT

LSD

Fmri

MEG

EEG

PET

5-HT Receptor

Microdosing

Neuroplasticity

Endocrine

Menstural Cycle Hormones

Australia Law on MDMA and Psilocybin

Research

Support the podcast

★ Support this podcast ★

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features